$IPXL Headlines Best Buy tops SP 500; Netflix snaps

New Post Public Reply Private Reply Replies (0) Message Board

Dec 11, 2013 at 4:11 PM

$IPXL Headlines

Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Citrix, Ruby Tuesday shares fall after hours 4:06 p.m. Oct. 9, 2013 - Wallace Witkowski
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
Tuesday’s movers: Cisco propels Dow to new record 4:16 p.m. March 5, 2013 - Sue Chang
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Impax: FDA finds continuing problems at plant 5:49 p.m. March 4, 2013 - MarketWatch.com
Impax shares resume trading, drop 19% 4:43 p.m. March 4, 2013 - Carla Mozee
An orderly pullback from multi-year highs 9:47 a.m. Sept. 20, 2012 - Michael Ashbaugh
Europe stock swoon deepens after U.S. data 11:11 a.m. Sept. 4, 2012 - Sara Sjolin
Shire sinks on generic Adderall approval 2:38 a.m. July 10, 2012 - MarketWatch.com
Stocks to watch Monday: Shire, Kirby, Tesla 5:59 a.m. June 25, 2012 - MarketWatch
Charting the 2012 uptrend 9:53 a.m. April 2, 2012 - Michael Ashbaugh
Nasdaq works off major technical breakout 11:00 a.m. Feb. 6, 2012 - Michael Ashbaugh
Impax jumps 10% on Parkinson's study 11:47 a.m. Aug. 15, 2011 - Val Brickates Kennedy
Impax leads drug stocks lower 1:05 p.m. June 8, 2011 - Val Brickates Kennedy
Ten decliners in Wednesday's market 9:50 a.m. June 8, 2011 - Tom Bemis
Impax drops 11% on downgrade 9:20 a.m. June 8, 2011 - Val Brickates Kennedy
Impax gets FDA warning letter for plant issues 7:11 a.m. June 6, 2011 - MarketWatch.com
S&P 500 holds tightly to the January peak 10:09 a.m. Jan. 26, 2011 - Michael Ashbaugh

Impax Laboratories Inc. Stock Upgraded (IPXL) 10:14 a.m. Dec. 6, 2013 - TheStreet.com
Impax Settles Litigation with Purdue Pharma - Analyst Blog 6:32 p.m. Dec. 5, 2013 - Zacks.com
Impax Labs Attains 52-Week High - Analyst Blog 2:11 p.m. Dec. 2, 2013 - Zacks.com
Short Interest Drops 28% For IPXL 4:19 p.m. Nov. 27, 2013 - TheStreet.com
Bull Of The Day: Impax 3:12 p.m. Nov. 27, 2013 - Seeking Alpha
Bull of the Day: Impax (IPXL) - Bull of the Day 5:06 a.m. Nov. 27, 2013 - Zacks.com
Impax Launches Generic Solaraze - Analyst Blog 5:30 p.m. Nov. 22, 2013 - Zacks.com
Actavis Cuts 350 Sales Positions in the U.S. - Analyst Blog 11:50 a.m. Nov. 22, 2013 - Zacks.com
Simcere Reports a Loss - Analyst Blog 1:57 p.m. Nov. 18, 2013 - Zacks.com
Akorn (AKRX) In Focus: Stock Jumps 8.1% - Tale of the Tape 9:11 a.m. Nov. 18, 2013 - Zacks.com
Anacor Rises on Positive Data - Analyst Blog 4:45 p.m. Nov. 14, 2013 - Zacks.com
Insider Trading Alert - IPXL, IPI, DNKN, PMTC And LRN Traded By Insiders 1:01 p.m. Nov. 14, 2013 - TheStreet.com
Narrow-than-Expected Loss at Pernix - Analyst Blog 10:20 a.m. Nov. 14, 2013 - Zacks.com
Actelion's Opsumit Cleared in Canada - Analyst Blog 5:00 p.m. Nov. 13, 2013 - Zacks.com
Narrower Q3 Loss at Supernus - Analyst Blog 1:33 p.m. Nov. 13, 2013 - Zacks.com
UPDATE: Janney Capital Markets Initiates Coverage on Impax Laboratories as The Last Mid-Cap Generics Company Standing 7:38 a.m. Nov. 13, 2013 - benzinga.com
Will Teva Pharmaceuticals Overcome Its Patent Cliff Worries? 6:22 p.m. Nov. 12, 2013 - Seeking Alpha
Mallinckrodt Misses on Earnings & Sales - Analyst Blog 2:07 p.m. Nov. 12, 2013 - Zacks.com
Arena Pharmaceuticals (ARNA) Worth Watching: Stock Surges 17.4% - Analyst Blog 9:02 a.m. Nov. 11, 2013 - Zacks.com
Impax Earnings Fall on Lower Revenues - Analyst Blog 12:20 p.m. Nov. 5, 2013 - Zacks.com

Upcoming Presentations, Stock Price Movements, and Patent Challenge Settlements - Research Report on Johnson & Johnson, Alexion, Intuitive Surgical, Medivation, and Impax 8:00 a.m. Dec. 6, 2013 - PR Newswire
Purdue Pharma L.P. Announces Resolution of OxyContin® (oxycodone HCl controlled-release) Tablets CII Patent Lawsuit with Impax Laboratories, Inc. 8:09 a.m. Dec. 3, 2013 - PR Newswire
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement 8:00 a.m. Dec. 3, 2013 - BusinessWire
Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3 8:30 a.m. Nov. 27, 2013 - BusinessWire
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%) 8:45 a.m. Nov. 21, 2013 - BusinessWire
Pre-Market Review: Star Scientific Inc., Pharmacyclics Inc., United Therapeutics Corp., and Impax Laboratories Inc. 8:19 a.m. Nov. 21, 2013 - PR Newswire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Impax Laboratories to Present at the 2013 Credit Suisse Healthcare Conference on November 14 9:00 a.m. Nov. 7, 2013 - BusinessWire
Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx 8:00 a.m. Nov. 6, 2013 - PR Newswire
Impax Laboratories Reports Third Quarter 2013 Results 4:01 p.m. Nov. 4, 2013 - BusinessWire
Under AAAResearchReports.com Microscope: Star Scientific Inc., Pharmacyclics Inc., Impax Laboratories Inc., and United Therapeutics Corp. 8:18 a.m. Oct. 30, 2013 - PR Newswire
Impax Laboratories and TOLMAR, Inc. Announce Final FDA Approval for Generic Solaraze(R) Gel (Diclofenac Sodium-3%) 6:30 a.m. Oct. 30, 2013 - BusinessWire
Impax Laboratories Confirms Patent Challenge Relating to Generic Atelvia(R) Delayed-Release Tablets, 35 mg 7:00 a.m. Oct. 25, 2013 - BusinessWire
Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star Scientific Inc., and Impax Laboratories Inc. 8:22 a.m. Oct. 8, 2013 - PR Newswire
Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2013 Financial Results 8:00 a.m. Oct. 8, 2013 - BusinessWire
Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinson's Disease on Their Largest Commercial Plan 9:00 a.m. Aug. 19, 2013 - PR Newswire
Impax Laboratories to Present at the Canaccord Genuity Annual Growth Conference 8:00 a.m. Aug. 13, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ABBV, IPXL, OMED and XOMA 7:51 a.m. Aug. 13, 2013 - ACCESSWIRE
Impax Laboratories Reports Second Quarter 2013 Results 3:02 p.m. Aug. 8, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ID Plans Secures Polaris Investment for Real Estate Boost

New Moves in Real Estate Tech Can you smell opportunity? Because it’s in the air down in Tampa where ID Plans just inked a deal with Polaris Growth Fund. We’re talking some serious private equity backing here aimed at ramping up what ID Plans can lay down in the commercial real estate sector. If you're not on this ride yet, it might be time to take a closer look....

ESI Motion's Role in Lockheed's Missile Defense Program

ESI Motion's Solar Drive Tech Joins the Defense Arena Picture this: ESI Motion Inc. just inked a deal with Lockheed Martin to supply Solar Array Drive Electronics (SADE) technology—a serious move in space tech. Now, ESI isn't just playing in the local Simi Valley sandbox; they're thrusting their tech into something much more critical—national defense. We're talking...

Right College Fit Crucial for Graduation Rates

Navigating College Choices: More Than Just a Hunch When it comes to picking the right college, a lot of folks think it's like shooting in the dark—it's more than just a blind dart throw at a life map. According to a new report from the College Board, aligning with the right academic institution isn't merely a nice-to-have deal; it fundamentally shifts the odds in favor...

Beta Bionics: Investors on Edge, Legal Moves Underway

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

David Cornue Brings Story Insights to SXSW 2027

Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...

?atwogang Leads Tiltify's Impact Creator Class of 2026

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Palmdale Propane Expands with Affordable Gas Buy

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

SELCO and Numerica Unite: A Merger That's All Heart

Big Merger in Credit Union World: SELCO and Numerica Sometimes, it ain't all about dollars and cents. That's the vibe I'm picking up from this merger of equals between SELCO Community and Numerica Credit Unions. This isn't a Wall Street hustle, it's hometown hustle—where the biggest reward isn't just a fat line at the bottom but seeing your community thrive. The Vision...

Domino’s Faces Legal Heat: Investors' Eyes On DPZ

Domino's Pizza Under the Legal Microscope Picture this, folks: Domino's Pizza (NASDAQ: DPZ) is caught in a legal whirlwind that might give its shareholders a rollercoaster of a read in the coming weeks. On the docket is a serious probe led by Johnson Fistel, a law outfit with quite the reputation for defending shareholder interests. The focus? Whether certain hot shots at...